CytomX Therapeutics, Inc. announced that Frederick W. Gluck is retiring from its board of directors, effective June 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +9.02% |
|
0.00% | -14.19% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.19% | 95.06M | |
+15.82% | 121B | |
+20.35% | 113B | |
+17.47% | 26.02B | |
-25.31% | 19.39B | |
-19.51% | 15.91B | |
-19.67% | 15.09B | |
-46.87% | 15.06B | |
+62.55% | 14.93B | |
+6.34% | 13.85B |
- Stock Market
- Equities
- CTMX Stock
- News CytomX Therapeutics, Inc.
- CytomX Therapeutics, Inc. Announces Retirement of Frederick W. Gluck from Board of Directors